URGN - Financial Reports List - UroGen Pharma Ltd. - IntrinsicAlpha

UroGen Pharma Ltd. URGN

Healthcare - Biotechnology - NASDAQ - US

$ 10.93

-2.41 %

$ 504 M

Market Cap

-3.69

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	4.40%	-44.19%	-89.32%
Annual Report	FY	10-K	2024-12-31	9.29%	-24.09%	-47.68%
Quarterly Report	Q3	8-K	2024-09-30	20.87%	-8.20%	-29.96%
Quarterly Report	Q2	8-K	2024-06-30	3.35%	-38.39%	-67.98%
Quarterly Report	Q1	8-K	2024-03-31	9.24%	-6.86%	-16.76%
Quarterly Report	Q4	8-K	2023-12-31	30.06%	7.90%	27.97%
Annual Report	FY	10-K	2023-12-31	28.52%	6.34%	17.09%
Quarterly Report	Q3	8-K	2023-09-30	29.54%	15.30%	25.36%
Quarterly Report	Q2	8-K	2023-06-30	27.31%	9.57%	17.81%
Quarterly Report	Q1	8-K	2023-03-31	26.75%	-6.41%	-0.40%

1